Mesenchymal Stem Cells: Alterations in Genome
NCT00836732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2013-09-30
Summary
The aim is to study small genetic alterations induced by cell culture in human mesenchymal stem cells in GMP condition.
Conditions
- Pened Chest Surgery for Programmes Coronary Bypass
Interventions
- PROCEDURE
-
harvest of a small bone marrow sample
harvest of a small bone marrow sample during open chest surgery
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Principal Investigators
-
Patricia Lemarchand, MD · Nantes UH - institut du thorax
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2012-03-31
- Completion
- 2012-03-31
Countries
- France
Study Locations
More Related Trials
-
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury
NCT04996966 ·Status: RECRUITING ·Phase: PHASE1
-
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
NCT05362786 ·Status: COMPLETED ·Phase: PHASE1
-
MSC Therapy in Liver Transplantation
NCT02260375 ·Status: RECRUITING ·Phase: PHASE1
-
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
NCT05520112 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles
NCT05520125 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients
NCT02472002 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
MSC and MC in Type 2 Diabetes Mellitus
NCT01719640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
NCT02685098 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
NCT07212335 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke
NCT06997939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)
NCT00587990 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
NCT04684602 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
NCT03239535 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease
NCT02287831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
NCT03321942 ·Status: UNKNOWN ·Phase: NA
-
Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema
NCT01306513 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus
NCT04441658 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
NCT04392206 ·Status: RECRUITING ·Phase: PHASE1
-
MSC and Kidney Transplant Tolerance (Phase A)
NCT02565459 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.
NCT02563366 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
NCT04093336 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
NCT00260338 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection
NCT03552848 ·Status: UNKNOWN ·Phase: NA
-
Stem Cell Therapy for Chronic Kidney Disease
NCT04869761 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
NCT06492798 ·Status: RECRUITING ·Phase: PHASE1/PHASE2